Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
Abstract Background Combination therapy of linezolid (LZD) and rifampicin (RFP) may be more effective than monotherapy for treating gram-positive bacterial infections, but several studies have suggested that RFP decreases LZD exposures, thereby increasing the risk of therapeutic failure and emergenc...
Main Authors: | Satsuki Hashimoto, Kyoko Honda, Kohei Fujita, Yuka Miyachi, Kazuya Isoda, Ko Misaka, Yukio Suga, Satoshi Kato, Hiroyuki Tsuchiya, Yukio Kato, Masaki Okajima, Takumi Taniguchi, Tsutomu Shimada, Yoshimichi Sai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Journal of Pharmaceutical Health Care and Sciences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40780-018-0123-1 |
Similar Items
-
Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients
by: Pan Yan, et al.
Published: (2023-11-01) -
Linezolid drug interactions: A retrospective study
by: Zeynep Ulku Gun, et al.
Published: (2020-06-01) -
A possible interaction between linezolid and digoxin: A case report of therapeutic drug monitoring
by: Zhu Yulin, et al.
Published: (2020-11-01) -
Genetic Profile of Linezolid-Resistant <i>M. tuberculosis</i> Clinical Strains from Moscow
by: Anastasia Ushtanit, et al.
Published: (2021-10-01) -
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trialResearch in context
by: Antigone Kotsaki, et al.
Published: (2023-02-01)